This page has been archived on the Web
Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.
Mint-Risperidon (2016-08-23)
- Starting date:
- August 23, 2016
- Type of communication:
- Drug Recall
- Subcategory:
- Drugs
- Hazard classification:
- Type III
- Source of recall:
- Health Canada
- Issue:
- Product Safety
- Audience:
- General Public, Healthcare Professionals, Hospitals
- Identification number:
- RA-60220
Affected Products
Mint-Risperidon
Reason
Out of specification result for an impurity during stability testing.
Depth of distribution
Pharmacies and Wholesalers - Canada (Ontario, Alberta, Saskatchewan, Quebec, British Columbia, Manitoba)
Affected products
Mint-Risperidon
DIN, NPN, DIN-HIM
DIN 02359812
Dosage form
Tablet
Strength
1 mg
Lot or serial number
EOD035001
Companies
- Recalling Firm
-
Mint Pharmaceuticals Inc.
1093 Meyerside Drive, Unit #1
Mississauga
L5T 1J6
Ontario
CANADA
- Marketing Authorization Holder
-
Mint Pharmaceuticals Inc.
1093 Meyerside Drive, Unit #1
Mississauga
L5T 1J6
Ontario
CANADA